"Virginia Cancer Specialists offers a dedicate team of medical oncologists, hematologists, oncology nurses, oncology pharmacists and a research department, all working on your behalf to provide comprehsensive, advanced cancer care in your community."

During the past decade, Virginia Cancer Specialists, PC conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 4 clinical trials were completed, i.e. on average, 26.7% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 2 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Virginia Cancer Specialists, PC" #1 sponsor was "Pfizer" with 4 trials, followed by "ADC Therapeutics S.A." with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Loxo Oncology, Inc." with 2 trials sponsored and "BeiGene" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Virginia Cancer Specialists, PC" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Chugai" with 1 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator, "Exelixis" with 1 trials as a collaborator and "GOG Foundation" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Virginia Cancer Specialists, PC" are "Breast Cancer" (2 trials), "Metastatic Breast Cancer" (2 trials), "Multiple Myeloma" (2 trials), "Ovarian Cancer" (2 trials) and "Advanced Breast Cancer" (1 trials). Many other conditions were trialed in "Virginia Cancer Specialists, PC" in a lesser frequency.

Most popular intervention types in "Virginia Cancer Specialists, PC" are "Drug" (17 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Rituximab" (3 trials), "Daratumumab" (2 trials), "Gemcitabine" (2 trials), "Lenalidomide" (2 trials) and "Loncastuximab Tesirine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Virginia Cancer Specialists, PC" are 16 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Virginia Cancer Specialists, PC". undefined are not yet recruiting, 9 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Virginia Cancer Specialists, PC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Virginia Cancer Specialists, PC, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".